Vitroscope raises $7M to turn living human tissue into drug discovery data
Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data
AI Overview
Vitroscope raised $7 million, a $5 million seed round co-led by Cerberus Ventures and YZR Capital plus $2 million in non-dilutive funding from the Research Council of Norway.
Why it matters
Vitroscope's perfusion platform keeps living tissue viable for days, and the round funds a 96-experiment version aimed at producing longitudinal drug-discovery data.